Cargando…
Novel Thiazole-Based SIRT2 Inhibitors Discovered via Molecular Modelling Studies and Enzymatic Assays
Recently, the development of sirtuin small molecule inhibitors (SIRTIs) has been gaining attention for the treatment of different cancer types, but also to contrast neurodegenerative disease, diabetes, and autoimmune syndromes. In the search for SIRT2 modulators, the availability of several X-crysta...
Autores principales: | Abbotto, Elena, Casini, Beatrice, Piacente, Francesco, Scarano, Naomi, Cerri, Elena, Tonelli, Michele, Astigiano, Cecilia, Millo, Enrico, Sturla, Laura, Bruzzone, Santina, Cichero, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535842/ https://www.ncbi.nlm.nih.gov/pubmed/37765125 http://dx.doi.org/10.3390/ph16091316 |
Ejemplares similares
-
Virtual Screening in the Identification of Sirtuins’ Activity Modulators
por: Abbotto, Elena, et al.
Publicado: (2022) -
Virtual Screening Combined with Enzymatic Assays to Guide the Discovery of Novel SIRT2 Inhibitors
por: Scarano, Naomi, et al.
Publicado: (2023) -
Paracrine ADP Ribosyl Cyclase-Mediated Regulation of Biological Processes
por: Astigiano, Cecilia, et al.
Publicado: (2022) -
Sirt6 inhibition delays the onset of experimental autoimmune encephalomyelitis by reducing dendritic cell migration
por: Ferrara, Giovanni, et al.
Publicado: (2020) -
NBD2 Is Required for the Rescue of Mutant F508del CFTR by a Thiazole-Based Molecule: A Class II Corrector for the Multi-Drug Therapy of Cystic Fibrosis
por: Brandas, Chiara, et al.
Publicado: (2021)